Evidence map›Paper›PMID 40093747›Full record

ArticleFrontiers in endocrinology2025

The crucial role of hypertension in determining latent classes of metabolic syndrome in northern Iran and predictive power of these classes in non-alcoholic fatty liver: a gender-based insight.

Bahareh Amirkalali, Parvin Hassanzadeh, Fatemeh Sheikholmolooki, Esmaeel Gholizadeh, Azam Doustmohammadian, Fahimeh Safarnezhad Tameshkel, Nima Motamed, Mansooreh Maadi, Masoudreza Sohrabi, Elham Sobhrakhshankhah and 2 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bahareh AmirkalaliGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Parvin HassanzadehGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Fatemeh SheikholmolookiDepartment of Nutrition, Health and Statistics Surveillance Research Center, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Esmaeel GholizadehGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Azam DoustmohammadianGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Fahimeh Safarnezhad TameshkelGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Nima MotamedDepartment of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Mansooreh MaadiGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Masoudreza SohrabiGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Elham SobhrakhshankhahGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Farhad Zamani *Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hossein Ajdarkosh *Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study investigates the subclasses of metabolic syndrome (Mets) and their relationship with non-alcoholic fatty liver (NAFLD) and the probable predictive role of serum vitamin D and CRP levels. Methods: This community-based, cross-sectional study was performed on adults in the framework of the Amol cohort prospective study (AmolCPS). Mets was defined as Adult Treatment Panel III criteria (ATP III) and ultrasound was used to diagnose NAFLD. Anthropometric and blood pressure measurements were conducted, and biochemical measurements were assessed after fasting. Data analysis included Latent class analysis, two-tailed χ2 statistics, one-way analysis of variance, and logistic regression using Mplus (version 7.4) and spss (version 26) softwares. Results: The study involved 2308 participants, with a mean age of 43.17 ± 12.30 years. Mets prevalence was 25.64%, with three identified classes: Mets with Hypertension (HTN), Mets without HTN (Non-HTN), and Low Risk. Mets with HTN had a high probability of at least four components, particularly high SBP. Non-HTN had at least three high probable components, especially high TG and low HDL but not high SBP and DBP. The low-risk class had a low probability of all components except low HDL in women. Serum vitamin D and CRP levels did not significantly predict Mets classes in men, while CRP level significantly predicted the HTN class in women (OR:1.03, CI:1.004-1.067). Both HTN, and Non-HTN Mets classes significantly increased the odds of NAFLD compared to the low risk class, especially in women (HTN class OR: 4.20 vs 2.94; non-HTN class OR: 5.60 vs 3.12 in women and men respectively). Conclusion: The latent class analysis in northern Iran identified three Mets classes: HTN, Non-HTN, and low-risk, with hypertension playing a crucial role in determining these classes. These classes were stronger predictors of NAFLD in women. Serum CRP and vitamin D levels did not emerge as significant predictors of the classes, except for serum CRP in the HTN class among women.

Indexed as

HypertensionMetabolic SyndromeNon-alcoholic Fatty Liver DiseaseAdultCross-Sectional StudiesFemaleHumansIranMaleMiddle AgedPrevalenceProspective StudiesRisk FactorsSex FactorsVitamin DVitamin DhypertensionIranlatent class analysismetabolic syndromenon-alcoholic fatty liver

Identifiers

PMID40093747
PMCPMC11906334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.